6% hydroxyethyl starch 130/0.4
HS-13-02-JP
Phase 3 small_molecule completed
Quick answer
6% hydroxyethyl starch 130/0.4 for Hypovolemia is a Phase 3 program (small_molecule) at Fresenius Kabi Australia Pty Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fresenius Kabi Australia Pty Limited
- Indication
- Hypovolemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed